Cargando…
The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665282/ http://dx.doi.org/10.1182/blood-2022-168844 |
_version_ | 1784831257514868736 |
---|---|
author | Tran, Huyen Deng, Lucy Wood, Nicholas Chen, Vivien M |
author_facet | Tran, Huyen Deng, Lucy Wood, Nicholas Chen, Vivien M |
author_sort | Tran, Huyen |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9665282 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The American Society of Hematology. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96652822022-11-16 The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia Tran, Huyen Deng, Lucy Wood, Nicholas Chen, Vivien M Blood Poster Abstracts The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665282/ http://dx.doi.org/10.1182/blood-2022-168844 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Poster Abstracts Tran, Huyen Deng, Lucy Wood, Nicholas Chen, Vivien M The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia |
title | The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia |
title_full | The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia |
title_fullStr | The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia |
title_full_unstemmed | The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia |
title_short | The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia |
title_sort | clinicalpathological features of vaccine-induced immune thrombocytopenia and thrombosis (vitt) following chadox1 (astrazeneca azd1222) vaccination and case outcomes in australia |
topic | Poster Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665282/ http://dx.doi.org/10.1182/blood-2022-168844 |
work_keys_str_mv | AT tranhuyen theclinicalpathologicalfeaturesofvaccineinducedimmunethrombocytopeniaandthrombosisvittfollowingchadox1astrazenecaazd1222vaccinationandcaseoutcomesinaustralia AT denglucy theclinicalpathologicalfeaturesofvaccineinducedimmunethrombocytopeniaandthrombosisvittfollowingchadox1astrazenecaazd1222vaccinationandcaseoutcomesinaustralia AT woodnicholas theclinicalpathologicalfeaturesofvaccineinducedimmunethrombocytopeniaandthrombosisvittfollowingchadox1astrazenecaazd1222vaccinationandcaseoutcomesinaustralia AT chenvivienm theclinicalpathologicalfeaturesofvaccineinducedimmunethrombocytopeniaandthrombosisvittfollowingchadox1astrazenecaazd1222vaccinationandcaseoutcomesinaustralia AT tranhuyen clinicalpathologicalfeaturesofvaccineinducedimmunethrombocytopeniaandthrombosisvittfollowingchadox1astrazenecaazd1222vaccinationandcaseoutcomesinaustralia AT denglucy clinicalpathologicalfeaturesofvaccineinducedimmunethrombocytopeniaandthrombosisvittfollowingchadox1astrazenecaazd1222vaccinationandcaseoutcomesinaustralia AT woodnicholas clinicalpathologicalfeaturesofvaccineinducedimmunethrombocytopeniaandthrombosisvittfollowingchadox1astrazenecaazd1222vaccinationandcaseoutcomesinaustralia AT chenvivienm clinicalpathologicalfeaturesofvaccineinducedimmunethrombocytopeniaandthrombosisvittfollowingchadox1astrazenecaazd1222vaccinationandcaseoutcomesinaustralia |